Literature DB >> 7101105

Effect of percutaneous transhepatic drainage upon liver function and postoperative mortality.

A Norlander, B Kalin, R Sundblad.   

Abstract

The results of the use of percutaneous transhepatic drainage in 109 patients between 1968 and 1980 were analyzed. The serum concentration of bilirubin decreased during the three week drainage period but not to normal values and more slowly than would be expected from normal hepatic bilirubin elimination, in site of adequate drained bile volumes. This decrease was most pronounced during the first week of drainage and in patients with high predrainage bilirubin levels. During refeeding of bile into the intestine, hepatic bilirubin excretion seemed to increase, possibly as a result of higher bile acid excretion. Of the 109 percutaneous transhepatic drainage patients, 58 underwent surgical treatment. Their postoperative mortality was compared with that of a control group of 65 patients, who were operated upon immediately after simple diagnostic percutaneous transhepatic cholangiography. It was not possible to demonstrate any significant difference in the postoperative mortality between these two groups. When the complications and, in addition, even mortality of the percutaneous transhepatic drainage procedure are taken into account, it seems doubtful that percutaneous transhepatic external drainage will benefit patients undergoing operation. This procedure may still be of great value in patients in whom only palliation is demanded.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7101105

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  18 in total

Review 1.  Current status of preoperative biliary drainage.

Authors:  Junko Umeda; Takao Itoi
Journal:  J Gastroenterol       Date:  2015-07-03       Impact factor: 7.527

2.  Total pancreatectomy for ductal cell carcinoma of the pancreas. An update.

Authors:  J R Brooks; D C Brooks; J D Levine
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

3.  Bile duct carcinoma. Diagnosis and treatment.

Authors:  D G Gibby; J B Hanks; H J Wanebo; D L Kaiser; C J Tegtmeyer; J G Chandler; R S Jones
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

4.  Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?

Authors:  H A Pitt; A S Gomes; J F Lois; L L Mann; L S Deutsch; W P Longmire
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

5.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

6.  Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.

Authors:  Seiji Kawasaki; Hiroshi Imamura; Akira Kobayashi; Terumasa Noike; Shiro Miwa; Shin-ichi Miyagawa
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

Review 7.  A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.

Authors:  Miguel E Sewnath; Thomas M Karsten; Martin H Prins; Erik J A Rauws; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

8.  Factors influencing survival after total pancreatectomy in patients with pancreatic cancer.

Authors:  A Andrén-Sandberg; I Ihse
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

9.  The treatment of acute cholangitis. Percutaneous transhepatic biliary drainage before definitive therapy.

Authors:  M E Pessa; I F Hawkins; S B Vogel
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

10.  Increase in serum bilirubin levels in obstructive jaundice secondary to pancreatic and periampullary malignancy--implications for timing of resectional surgery and use of biliary drainage.

Authors:  S D Mansfield; G Sen; K Oppong; B C Jacques; C B O'Suilleabhain; D M Manas; R M Charnley
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.